Address

Real-world evidence Research

Biopharmaceutical manufacturers are turning to health economics and outcomes research (HEOR) to obtain real-world evidence (RWE) that can support and improve their drugs. Using HEOR to gather RWE helps biopharma companies address three forces reshaping how they do business:

  • Competition in the biopharmaceutical manufacturing industry
  • Interest from regulators, policymakers and patient advocacy groups
  • Incentives from payers to enter into value-based contracts that base payment on outcomes

Generating Insights from Real-World Data

Innovate Research is a leading CRO delivering Real World Evidence studies in India, empowering pharmaceutical companies, medical device manufacturers, and healthcare leaders with actionable insights. Our expertise lies in collecting and analyzing high-quality real-world clinical data from everyday healthcare settings. This supports regulatory decisions, market access strategies, safety evaluations, and assessments of treatment effectiveness.

We focus on scientific rigor, data integrity, and compliance to ensure every Real-world evidence study in India delivers reliable, evidence-based outcomes that matter.

Why Real-World Evidence Studies Matter

Real World Evidence studies gather data from routine medical practice, outside the strict controls of traditional clinical trials. Sources include hospital records, patient registries, electronic medical records (EMRs), insurance claims, and patient-reported outcomes. This approach reveals how treatments perform in diverse, real-life populations; showing safety profiles, long-term effectiveness, and healthcare resource use.

In India, demand for Real World Evidence studies is rising fast. Our country’s vast and varied patient groups, along with growing regulatory needs from bodies like CDSCO, make RWE essential for post-marketing surveillance, pricing negotiations, and personalized medicine strategies.

Our Real-World Evidence Services

Innovate Research provides end-to-end solutions for Real World Evidence studies, tailored to your needs:

  • Study Design and Protocol Development: Creating focused plans that align with regulatory and business goals.
  • Data Source Identification and Feasibility: Partnering with hospitals, clinics, and databases to access relevant Indian data.
  • Retrospective and Prospective Observational Studies: Analyzing past records or tracking ongoing patient journeys.
  • Patient Registries and Post-Marketing Studies: Building long-term databases for safety monitoring and outcomes of research.
  • Data Validation, Quality Checks, and Analysis: Ensuring accuracy through cleaning, standardization, and advanced statistical methods.

We prioritize ethical standards, data privacy (including India’s DPDP Act), and real-world relevance to produce trustworthy results.

Why Partner with Us for Real World Evidence Studies?

Choosing Innovate Research for Real World Evidence studies in India means gaining clear advantages:

  • Extensive networks with hospitals and investigators across urban and rural India for broad data access.
  • Proven experience managing complex, messy real-world datasets with high accuracy.
  • Blend of scientific depth and efficient operations to deliver insights on time.
  • Transparent processes, from data collection to final reporting, with validated methods.
  • Track record of evidence that drives regulatory approvals, HTA submissions, and commercial success.

We turn real-world data into strategic value, helping you make informed decisions. Partner with Innovate Research for Real-world evidence studies India that combine local insight with global standards. Contact us to start generating evidence that shapes healthcare decisions.

FAQs About Real-World Evidence Studies

Real-World Evidence studies use data from everyday healthcare, like EMRs and claims, to assess treatment safety, effectiveness, and outcomes beyond clinical trials.
They involve partnering with local hospitals and registries, designing ethical protocols, collecting and validating data, then analyzing it for regulatory or market insights.
Common sources include electronic health records, patient registries, claims databases, hospital systems, and patient surveys—tailored to India’s diverse healthcare landscape.
Yes, we handle both; supporting CDSCO and international standards like FDA/EMA while leveraging India’s unique patient data for robust, compliant evidence.